Basel, Basel, Switzerland
• >4.5 years experience in end-to-end clinical trial management, including study design and set-up, conduct, monitoring, and closure, ensuring compliance with ICH-GCP and regulatory standards in diverse therapeutic areas • Phase I and III experience with vaccines and drug molecules, clinical study experience with IVD medical devices • Instructor for Swiss Ethics and Transcelerate accredited GCP course for investigators • Scientist with 15+ years in oncology • 13+ publications in high-impact, peer-reviewed journals, with significant research funding (ORCID link: https://orcid.org/0000-0002-4060-4218) • Honorary Mentor and advisor to 2 knowledge-based oncology solutions companies (in stealth mode), providing strategic and scientific guidance for developing solutions for key stakeholders (patients and oncologists)
- Clinical Trial management - Protocol, ICF and study documentation development, ethics and regulatory submissions - Site staff and monitor trainings - Monitoring responsible leading team of regional monitors - Project acquisition (grant writing), publication writing - Quality support- SOP writing, CTMS set up - Teaching GCP course for Investigators - Member of 'Human Subject Research' desk to provide scientific and ethical guidance on projects involving human before submission to ethical/ regulatory bodies
- Protocol, ICF, study documentation development - Training material development - Clinical Operations - Monitoring (on-site and central) - Quality support
Advisor/ Mentor to provide strategic guidance and scientific input on development of customized solutions for key stakeholders in oncology i.e., healthcare professionals
- Advisor and mentor to provide strategic guidance on the development of scientific strategy for developing personalised products and services for cancer patients
During my post-doctoral research with Prof. Gerhard Christofori (a world-renowned oncologist), I led, managed and collaborated across multi-functional teams of post-doctoral researchers, graduate students, Master's students, bio-informaticians and technicians to successfully complete the projects outlined below: • Discovered a novel long non-coding RNA ‘ET-20’ and its role in breast cancer (manuscript in revision). • Discovered the importance of Pygopus2-histone interaction in breast cancer progression (published in Cancer Research). This project was done in collaboration with the renowned molecular and developmental biologist, Prof. Konrad Basler (from University of Zurich). • ‘Tool development’: Developed and contributed a new cancer cell line, PyMT-1099 for preclinical research (published in Scientific Reports). • ‘Resource development’: Performed transcriptomics on cancer models to develop a precious in silico data mining resource for metastasis-related target discoveries. Was awarded 2 research grants for my project on “the role of long non-coding RNA in breast cancer” 1) University of Basel Research Fund for Excellent Junior Researchers (special funding from the L.&Th. La Roche Foundation for promotion of young researchers clinical research; 2019-2020). 2) Krebsliga Beider Basel Grant, Basel (2016-2017). Please click the links below to see the published research from my post-doc.